Keywords: ایمونوتراپی سرطان; Liposome; Cancer immunotherapy; Cross-presentation; Adjuvant; Tumor microenvironment; Cellular immunity;
مقالات ISI ایمونوتراپی سرطان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی سرطان; Nanoparticles; Vaccines; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Renal cell carcinoma; Metastasectomy; Targeted Cancer Therapy; Cancer Immunotherapy; Vascular endothelial growth factor;
Keywords: ایمونوتراپی سرطان; Indoleamine 2,3-dioxygenase 1; Imidazothiazoles; Multicomponent reactions; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; cancer immunotherapy; dendritic cell vaccine; dinoprostone; sulprostone;
Keywords: ایمونوتراپی سرطان; BG-DCs; dendritic cells matured with oncolysate-pre-loaded bacterial ghosts plus interferon gamma; BG; bacterial ghost; CFSE; carboxyfluorescein succinimidyl ester; DAMP; damage-associated molecular pattern; DC; dendritic cell; ELISPOT; enzyme-linked immu
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Immune evasion; Applied probability; Stochastic processes; 00-01; 99-00;
Keywords: ایمونوتراپی سرطان; Tryptophan 2, 3-dioxygenase; Tryptophan; Kynurenine; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Biliary Tract Cancers; Cancer Immunotherapy; Vaccines; Checkpoint Inhibitor Therapy; Cholangiocarcinoma; Adoptive T cell Therapy;
Keywords: ایمونوتراپی سرطان; Immuno-oncology; Cancer immunotherapy; Cancer genomics; Somatic evolution; Intra-tumour heterogeneity;
Keywords: ایمونوتراپی سرطان; Peptide antigen; Nanoparticle; Endosomal escape; Antigen cross-presentation; Vaccines; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Anti-tumor immunity; Tumor-immune escape;
Keywords: ایمونوتراپی سرطان; Bioanalysis; Fluoroimmunoassay; Cancer immunotherapy; Therapeutic monoclonal antibodies; Bevacizumab; Cetuximab;
Keywords: ایمونوتراپی سرطان; Heat shock protein; Cancer immunotherapy; DNA vaccine; Cellular vaccine;
Keywords: ایمونوتراپی سرطان; Immuno-oncology; Cancer immunotherapy; Small molecules; Inhibitors; Crystal structures;
Keywords: ایمونوتراپی سرطان; APC; antigen-presenting cell; ATG; autophagy-related gene; ATP; adenosine triphosphate; ANXA1; annexin A1; BECN1; beclin-1; CD; cluster of differentiation; CRT; calreticulin; CTL; cytotoxic T lymphocyte; (CTLA)-4; CTL associated protein-4; DAMP; danger-as
Keywords: ایمونوتراپی سرطان; Immune escape; Crystal structures; IDO1 inhibitors; Cancer immunotherapy; KP; kynurenine pathway; Trp; tryptophan; KYN; kynurenine; IDO1; indoleamine 2,3-dioxygenase 1; IDO2; indoleamine 2,3-dioxygenase 2; TDO; tryptophan 2,3-dioxygenase; IFN; interferon;
Keywords: ایمونوتراپی سرطان; Preanalytical variability; Biospecimen science; Cancer immunotherapy; Biomarker;
Keywords: ایمونوتراپی سرطان; Cancer Immunotherapy; Nanoparticles; Antigenic Peptides; Oligodeoxynucleotides; Immunomodulatory siRNA; Antigenic pDNA; Immune check point inhibitor;
Keywords: ایمونوتراپی سرطان; Dendritic cells; Cancer immunotherapy; Image processing; Pattern recognition; Phase contrast microsocopy; Computer vision;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Brain metastases; Melanoma; CTLA-4; PD-1/PD-L1; Glioblastoma multiforme;
Keywords: ایمونوتراپی سرطان; Nanotechnology; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Tumor microenvironment;
Keywords: ایمونوتراپی سرطان; Vaccine; Lymph node; Delivery; Adjuvant; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Nanomedicine; Tumor associated macrophages; Cancer immunotherapy; Mononuclear phagocyte system; Drug delivery; Tumor microenvironment;
Keywords: ایمونوتراپی سرطان; Alginate; Ovalbumin; DC targeting; Antigen delivery; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Bioengineered spider silk spheres; CpG-siRNA; STAT3; Targeted delivery; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Melanoma; Melanocyte; Melanoma antigen; Tumor-associated antigen; Melanoma marker; Anti-melanoma antibody; Melanoma diagnosis; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Nanoparticles; Cancer immunotherapy; Targeted drug delivery;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Immune checkpoint; Monoclonal antibodies; Resistance; Interferon; T lymphocytes;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Checkpoint blockade; Adoptive cell therapy; Nanoparticles;
Keywords: ایمونوتراپی سرطان; Cytotoxic T lymphocyte antigen-4; Programmed cell death-1; Cancer immunotherapy; Tumor immunology; Lymph node; Drug delivery systems; Controlled release; Therapeutic antibody; Immune-related associated toxicity;
Keywords: ایمونوتراپی سرطان; ETC; electron transport complexes; ROS/RNS; reactive oxygen or nitrogen spices; âÏm; mitochondrial inner membrane potential; TCA; TriCarboxylic acid cycle; MPTP; mitochondrial permeability transition pore; mtDNA; mitochondrial DNA; ND5; NADH dehydrogen
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Gamma chain cytokines; Hematopoietic malignancies; Solid cancers; Immunostimulation
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Monoclonal antibodies; Renal cell carcinoma; Prostate cancer; Urothelial cancer; Immune checkpoint inhibitors; CTLA-4; PD-1;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Nanovaccine; Antigen delivery; Lymph node; Dendritic cell targeting;
Keywords: ایمونوتراپی سرطان; Polymeric conjugate; Cancer immunotherapy; Antigen delivery; Hyaluronic acid; Foreignization;
Keywords: ایمونوتراپی سرطان; cancer immunotherapy; PD-1; CTLA-4; checkpoint blockade; MDSCs
Keywords: ایمونوتراپی سرطان; leukemia-initiating cells; tumor microenvironment; myeloid-derived suppressor cells; dendritic cells; tumor-associated macrophages; cancer immunotherapy
Keywords: ایمونوتراپی سرطان; cancer immunotherapy; cellular therapy; cord blood; expansion
Keywords: ایمونوتراپی سرطان; Programmed death-1; Programmed death-1 ligand 1; Pleomorphic carcinoma of the lung; Sarcomatoid carcinoma of the lung; Cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Galactosylated liposome; Dendritic cell targeted; Mucosal vaccine; Antigen delivery; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Targeted nanoparticle delivery; Myeloid cells; Dendritic cells; Tumor-associated macrophages;
Keywords: ایمونوتراپی سرطان; Nanoparticles; Cancer immunotherapy; Tumor microenvironment; Vaccine; Immunosuppression;
Keywords: ایمونوتراپی سرطان; ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytolysis; CDR; complementarity determining region; Fab; fragment antigen binding; H; antibody heavy chain; L; antibody light chain; Le; Lewis glycan epitope; PDB; protein data bank
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Tumor microenvironment; Therapeutic vaccination; Adoptive T cell therapy; Nanoparticles; Porous scaffolds
Keywords: ایمونوتراپی سرطان; Cancer Immunology; Cancer immunotherapy; Monoclonal antibody; Cancer vaccine; History of immunology; Combination treatment;
Keywords: ایمونوتراپی سرطان; Aging; Immune system; Innate immune system; Adaptive immune system; Cancer vaccines; Cancer immunotherapy;
Keywords: ایمونوتراپی سرطان; Beta-tricalcium phosphate; In vivo and in vitro immunostimulatory effects; Adjuvant; Cancer immunotherapy
Keywords: ایمونوتراپی سرطان; regenerative medicine; cancer immunotherapy; T cell reprogramming;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Immune resistance; T-cell response